Source: OTC Breaking News

ISR: Respondents Average 3.2 Small Molecule Sterile Injectables in Their Development Pipelines

Informing the Pharmaceutical Drug Development, Manufacturing, and Commercialization Industry CARY, NC / ACCESSWIRE / August 3, 2017 / Industry Standard Research's (ISR's) Small Molecule Sterile Injectable Drug Product Manufacturing Overview and Outlook report looks specifically at the portfolios and pipelines of small molecule sterile injectable outsourcers to gauge future demand among outsourcers, to understand how [...]

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Kevin Olson's photo - CEO of Industry Standard Research

CEO

Kevin Olson

CEO Approval Rating

70/100

Read more